Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Bullboard Posts
Comment by Balzdepeon Sep 15, 2017 9:26am
92 Views
Post# 26700143

RE:RE:What a bunch of garbage!

RE:RE:What a bunch of garbage!InMed has been approached by another company with an 
alternative in vitro production approach, but InMed has elected to pursue its own proprietary in vivo approach. On June 1, 2016, InMed filed a provisional patent application (USPTO No. 62/344,248) covering its inventions in the in vivo enzymatic biosynthesis of cannabinoids.

This is probably the difference in patents. In vitro vs in vivo.


1.In vivo is an experiment or testing that is done inside the living organism or in its natural environment while in vitro is an experiment that is done outside of the living organism, usually in a test tube or Petri dish.
2.In vivo testing is more expensive and time consuming than in vitro testing which provides quicker results.
3.While most biological experiments are done in vitro, it is less precise than experiments done in vivo because it does not simulate the actual conditions inside the organism.
4.In vivo experiments and testing have many restrictions because it deals with live animals while in vitro does not.

Bullboard Posts